Skin and Tissue Substitutes - MEDICAID - INDIANA (New)
Humana Indiana Medicaid has established new coverage criteria for skin and tissue substitutes (cellular and acellular matrices) effective May 20, 2026. Coverage is limited to two indications: partial- and full-thickness diabetic foot ulcers (DFU) and chronic venous leg ulcers (VLU), both >4 weeks duration, when used with standard wound therapy and meeting specific clinical prerequisites. All other indications are not covered. This is a historical material discovery—the policy became effective over 4 months prior to analysis date (2026-10-15).